ask="N/A"
ask_size="N/A"
average_daily_volume="1330440"
bid="41.47"
bid_size="100"
book_value="11.83"
change="+1.01"
change_from_200_day_moving_average="-11.93"
change_from_50_day_moving_average="1.11"
change_from_52_week_high="-38.65"
change_From_52_week_low="10.08"
change_in_percent="+2.50%"
close="41.46"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.55"
ebitda="-384.49M"
eps_estimate_current_year="-4.82"
eps_estimate_next_quarter="-1.33"
eps_estimate_next_year="-5.05"
ex_dividend_date="N/A"
float_shares="70877000"
high="41.69"
high_52_weeks="80.11"
last_trade_date="2/2/2017"
last_trade_price="41.46"
last_trade_size="62014"
last_trade_time="4:00pm"
low="39.73"
low_52_weeks="31.38"
market_capitalization="3.56B"
moving_average_200_day="53.39"
moving_average_50_day="40.35"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="63.57"
open="40.76"
pe_ratio="N/A"
peg_ratio="-0.18"
percent_change_from_200_day_moving_average="-22.34%"
percent_change_from_50_day_moving_average="+2.76%"
percent_change_from_52_week_high="-48.25%"
percent_change_from_52_week_low="+32.12%"
previous_close="40.45"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.42"
price_per_sales="93.17"
revenue="37.26M"
shares_outstanding="85813000"
short_ratio="8.69"
stock_exchange="NMS"
symbol="ALNY"
volume="1032594"
weeks_range_52="31.38 - 80.11"
